Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Keep informed on insider trading with our comprehensive news coverage. Explore the latest insider stock trades, follow insider trading activity, and dive into detailed reports on recent cases. Whether you’re monitoring the markets or interested in today’s top headlines, our insider trades tracker provides timely insights and updates.
CAMBRIDGE, MA—Anna Protopapas, a director at Mersana Therapeutics, Inc. (NASDAQ:MRSN), lately offered shares of the corporate’s frequent inventory valued at $5,009. In line with a Type 4 submitting with the Securities and Alternate Fee, the transaction occurred on January 16,…
CAMBRIDGE, MA — On January 15, Ashish Mandelia, Vice President and Chief Accounting Officer at Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical firm with a market capitalization of $76 million, executed a collection of inventory transactions, as disclosed in a…
SAN FRANCISCO—Kelly Rodriques, the Chief Govt Officer of Forge World Holdings, Inc. (NYSE:FRGE), not too long ago bought 50,000 shares of the corporate’s frequent inventory. The shares have been bought at a volume-weighted common value of $0.8041, amounting to a…
Joseph Baroldi, Government Vice President and Chief Enterprise Officer at Ionis Prescription drugs Inc. (NASDAQ:IONS), not too long ago disclosed the sale of firm shares valued at roughly $144,861. The transactions, dated January 16, concerned the sale of 4,430 shares…
CARLSBAD, CA—Amid Ionis Prescribed drugs Inc’s (NASDAQ:IONS) difficult 12 months marked by a 38% inventory decline and buying and selling close to its 52-week low of $31.40, Geary Richard S, Govt Vice President and Chief Improvement Officer, not too long…
Brian Birchler, Government Vice President of Company and Growth Operations at Ionis Prescription drugs Inc. (NASDAQ:IONS), lately bought 5,400 shares of the corporate’s widespread inventory. The shares have been bought at a median value of $32.70 every, amounting to a…
Bennett C. Frank, Govt Vice President and Chief Scientific Officer at Ionis Prescription drugs Inc. (NASDAQ:IONS), lately reported a major inventory transaction. Based on the most recent SEC submitting, Frank bought 6,752 shares of Ionis widespread inventory on January 16,…
These transactions have been a part of a routine course of involving automated gross sales to cowl tax obligations associated to restricted inventory models. After these transactions, Devers holds 15,937 shares of Ionis frequent inventory. Moreover, Devers was granted 33,000…
Patrick R. O’Neil, Government Vice President, Chief Authorized Officer, and Basic Counsel at Ionis Prescription drugs Inc (NASDAQ:IONS), offered 7,360 shares of the corporate’s widespread inventory on January 16, 2025. The shares have been offered at a weighted common value…
CARLSBAD, Calif. — Brett Monia, Chief Govt Officer of Ionis Prescribed drugs Inc. (NASDAQ:IONS), just lately bought a good portion of his holdings within the firm. In accordance with a current SEC submitting, Monia bought 33,445 shares of Ionis frequent…
